Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D08BCU
|
||||
Former ID |
DIB005058
|
||||
Drug Name |
U-90042
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Anxiety disorder [ICD9: 300, 311; ICD10:F32, F40-F42] | Terminated | [1] | ||
Company |
Pharmacia & Upjohn Co
|
||||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C17H13ClN6O
|
||||
Canonical SMILES |
c12n(c3c(c4=NCCn14)cc(cc3)Cl)cnc2c1nc(on1)C1CC1
|
||||
CAS Number |
CAS 134516-99-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor | Target Info | Modulator | [2] | |
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001470) | ||||
REF 2 | U-90042, a sedative/hypnotic compound that interacts differentially with the GABAA receptor subtypes. J Pharmacol Exp Ther. 1995 Nov;275(2):761-7. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.